Márcia de Figueiredo Pereira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Márcia de Figueiredo Pereira has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Amanda de Deus Ferreira Alves
Universidade Federal Rural de Pernambuco
2 shared publications - Valdemiro Amaro da Silva Júnior
Department of Veterinary Medicine, Federal Rural University of Pernambuco, Dom Manuel de Medeiros Street, s/n, Dois Irmãos, Recife, PE, 52171-900, Brazil
2 shared publications Allynneide Emannuelly da Silva Rodrigues
Médico(a) Veterinário(a) Autônomo(a), Recife, Pernambuco, Brasil
1 shared publicationAna Luiza N.G. Bessa
Hospital Veterinário de Recife, Brazil
1 shared publication- Ana Paula Veras Sobral
Universidade de Pernambuco, Brazil
1 shared publication - Andrea Alice da Fonseca Oliveira
Universidade Federal Rural de Pernambuco, Brazil
1 shared publication
Latest Publications
- Open Access
- 9 March 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (4)
Caracterização clínico-patológica e pesquisa de COX-2, CEA e CA15.3 em gatas com neoplasias mamárias
As neoplasias da glândula mamária têm origem multifatorial e são classificadas como o principal tipo de neoformação que acomete as gatas. O diagnóstico é obtido a partir da análise histopatológica, onde é possível determinar o tipo e o grau histológico do tumor mamário. Mais recentemente, os biomarcadores teciduais permitiram análises mais precisas quanto ao grau de malignidade dos tumores, havendo uma tentativa de utilizar marcadores séricos para diagnosticar precocemente micronódulos e metástases. Assim, este estudo teve como objetivo caracterizar o perfil clínico e avaliar os níveis séricos de antígeno carcinoembrionário (CEA) e antígeno cancerígeno 15.3 (CA15.3), quantificados por ELISA. Além disso, objetivou-se definir o diagnóstico histopatológico e identificar o perfil imuno-histoquímico da ciclooxigenase-2 (COX-2) nas neoplasias mamárias. O estudo foi realizaodo em 49 gatas, 38,78% não eram castradas e 59,18% já haviam sido submetidas a hormônios contraceptivos. As neoplasias malignas representaram 76,92%, sendo os tipos cribriforme, tubulopapilar e tubular os mais frequentes. Os níveis séricos médios de CA15,3 e CEA foram 2,4108 ± 0,4748 U/mL e 0,0024 µg/L, respectivamente. O tumor mamário nas gatas possui alta malignidade, podendo coexistir mais de um tipo histológico em gatas com múltiplos nódulos. A imunoexpressão de COX-2 e não mostrou associação significativa com o aparecimento de tumores mamários. O uso dos marcadores tumorais CEA e CA15.3 não foi eficiente em gatas com lesões mamárias.
- 9 March 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (4)
Open AccessCaracterização clínico-patológica e pesquisa de COX-2, CEA e CA15.3 em gatas com neoplasias mamárias
As neoplasias da glândula mamária têm origem multifatorial e são classificadas como o principal tipo de neoformação que acomete as gatas. O diagnóstico é obtido a partir da análise histopatológica, onde é possível determinar o tipo e o grau histológico do tumor mamário. Mais recentemente, os biomarcadores teciduais permitiram análises mais precisas quanto ao grau de malignidade dos tumores, havendo uma tentativa de utilizar marcadores séricos para diagnosticar precocemente micronódulos e metástases. Assim, este estudo teve como objetivo caracterizar o perfil clínico e avaliar os níveis séricos de antígeno carcinoembrionário (CEA) e antígeno cancerígeno 15.3 (CA15.3), quantificados por ELISA. Além disso, objetivou-se definir o diagnóstico histopatológico e identificar o perfil imuno-histoquímico da ciclooxigenase-2 (COX-2) nas neoplasias mamárias. O estudo foi realizaodo em 49 gatas, 38,78% não eram castradas e 59,18% já haviam sido submetidas a hormônios contraceptivos. As neoplasias malignas representaram 76,92%, sendo os tipos cribriforme, tubulopapilar e tubular os mais frequentes. Os níveis séricos médios de CA15,3 e CEA foram 2,4108 ± 0,4748 U/mL e 0,0024 µg/L, respectivamente. O tumor mamário nas gatas possui alta malignidade, podendo coexistir mais de um tipo histológico em gatas com múltiplos nódulos. A imunoexpressão de COX-2 e não mostrou associação significativa com o aparecimento de tumores mamários. O uso dos marcadores tumorais CEA e CA15.3 não foi eficiente em gatas com lesões mamárias.
- Open Access
- 1 January 2021
- Published by Universidade Federal do Rio Grande do Sul in Acta Scientiae Veterinariae
- Vol. 49
Splenic Stromal Sarcoma in a Labrador Dog
Background: Splenic stromal neoplasms are a heterogeneous group of tumors that shares the morphology of spindle cells, and are considered a primary mesenchymal neoplasm of the spleen. Among these neoplasms, some are as yet unclassified. Although stromal neoplasms represent 25 a 50% of dog splenic neoplasms in dogs, subtypes rarely occur alone. As these neoplasms are difficult to diagnose in the routine veterinary medical examination, the objective of this article was to report a case of splenic stromal sarcoma in a dog treated at a private veterinary hospital in Recife, Pernambuco, Brazil. Case: An 8-year-old male labrador dog was treated at a veterinary hospital for an initial clinical suspicion of gastroenteritis. Clinical examinations showed anemic ocular mucosa and a distended abdomen. Considering the animal’s condition, blood count, serum biochemistry, and abdominal ultrasonography (US) were requested. The laboratory tests revealed anemia, thrombocytopenia, leukocytosis with neutrophilia, and changes in the indices of alanine aminotransferase (ALT) and alkaline phosphatase (ALP), among other findings. Abdominal ultrasound showed hepatomegaly, diffuse splenomegaly, a neoformation in the spleen suggestive of splenic neoplasia, and mild cystic prostatic hyperplasia. The dog underwent exploratory laparotomy with splenectomy. During the procedure, a nodule was found attached to the spleen. It was removed, fixed in a 10% neutral buffered formalin solution, and sent for histopathological and immunohistochemical examinations (vimentin, S100, desmin, MyoD1, HHF35, CD31, and alpha smooth muscle actin). The histopathological diagnosis was poorly differentiated spindle cell splenic sarcoma, compatible with splenic stromal sarcoma. Immunohistochemistry showed neoplastic cells immunoreactive for vimentin and S100, and it was not reactive for other markers. Based on the immunohistochemical and morphological profile, the diagnosis of splenic stromal sarcoma was confirmed. Discussion: Dogs affected by splenic neoplasms are generally aged between three and 17 years, and clinically present withanorexia, emesis, lethargy, weight loss, and abdomen distension, which were observed in the present case. However, a purelyclinical diagnosis is disputable, since other diseases can present the same signs. Thus, complementary exams are essential for a correct diagnosis. Laboratory changes in blood count and serum biochemistry are considered nonspecific for splenic neoplasms, with neutrophilic leukocytosis and anemia being consistent with paraneoplastic syndromes frequently diagnosed in small animals. Microscopically, splenic stromal sarcomas are characterized by focal splenic nodules composed of cohesive polygonal to spindle-shaped cell layers. The cells usually exhibit anisokaryosis and often have large oval to round vesicular nuclei and, occasionally, multinucleated cells. They have large areas of necrosis, diffuse or nodular lymphoid aggregates, and foci of extramedullary hematopoiesis, consistent with the histopathological examination reported in the present case. The immunohistochemical analysis included evaluation of seven markers to elucidate the histogenesis of the neoplasm, with the anti-vimentin and anti-S100 markers demonstrating positive cytoplasmic immunoreactivity, revealing the mesenchymal origin of the neoplasm. Thus, the definitive diagnosis was splenic stromal sarcoma, a rare and aggressive neoplasm. Keywords: spleen, histopathology, immunohistochemistry, neoplasm. Descritores: baço, histopatologia, imunohistoquímica, neoplasia
- 1 January 2021
- Published by Universidade Federal do Rio Grande do Sul in Acta Scientiae Veterinariae
- Vol. 49
Open AccessSplenic Stromal Sarcoma in a Labrador Dog
Background: Splenic stromal neoplasms are a heterogeneous group of tumors that shares the morphology of spindle cells, and are considered a primary mesenchymal neoplasm of the spleen. Among these neoplasms, some are as yet unclassified. Although stromal neoplasms represent 25 a 50% of dog splenic neoplasms in dogs, subtypes rarely occur alone. As these neoplasms are difficult to diagnose in the routine veterinary medical examination, the objective of this article was to report a case of splenic stromal sarcoma in a dog treated at a private veterinary hospital in Recife, Pernambuco, Brazil. Case: An 8-year-old male labrador dog was treated at a veterinary hospital for an initial clinical suspicion of gastroenteritis. Clinical examinations showed anemic ocular mucosa and a distended abdomen. Considering the animal’s condition, blood count, serum biochemistry, and abdominal ultrasonography (US) were requested. The laboratory tests revealed anemia, thrombocytopenia, leukocytosis with neutrophilia, and changes in the indices of alanine aminotransferase (ALT) and alkaline phosphatase (ALP), among other findings. Abdominal ultrasound showed hepatomegaly, diffuse splenomegaly, a neoformation in the spleen suggestive of splenic neoplasia, and mild cystic prostatic hyperplasia. The dog underwent exploratory laparotomy with splenectomy. During the procedure, a nodule was found attached to the spleen. It was removed, fixed in a 10% neutral buffered formalin solution, and sent for histopathological and immunohistochemical examinations (vimentin, S100, desmin, MyoD1, HHF35, CD31, and alpha smooth muscle actin). The histopathological diagnosis was poorly differentiated spindle cell splenic sarcoma, compatible with splenic stromal sarcoma. Immunohistochemistry showed neoplastic cells immunoreactive for vimentin and S100, and it was not reactive for other markers. Based on the immunohistochemical and morphological profile, the diagnosis of splenic stromal sarcoma was confirmed. Discussion: Dogs affected by splenic neoplasms are generally aged between three and 17 years, and clinically present withanorexia, emesis, lethargy, weight loss, and abdomen distension, which were observed in the present case. However, a purelyclinical diagnosis is disputable, since other diseases can present the same signs. Thus, complementary exams are essential for a correct diagnosis. Laboratory changes in blood count and serum biochemistry are considered nonspecific for splenic neoplasms, with neutrophilic leukocytosis and anemia being consistent with paraneoplastic syndromes frequently diagnosed in small animals. Microscopically, splenic stromal sarcomas are characterized by focal splenic nodules composed of cohesive polygonal to spindle-shaped cell layers. The cells usually exhibit anisokaryosis and often have large oval to round vesicular nuclei and, occasionally, multinucleated cells. They have large areas of necrosis, diffuse or nodular lymphoid aggregates, and foci of extramedullary hematopoiesis, consistent with the histopathological examination reported in the present case. The immunohistochemical analysis included evaluation of seven markers to elucidate the histogenesis of the neoplasm, with the anti-vimentin and anti-S100 markers demonstrating positive cytoplasmic immunoreactivity, revealing the mesenchymal origin of the neoplasm. Thus, the definitive diagnosis was splenic stromal sarcoma, a rare and aggressive neoplasm. Keywords: spleen, histopathology, immunohistochemistry, neoplasm. Descritores: baço, histopatologia, imunohistoquímica, neoplasia
- Open Access
- 1 January 2021
- Published by Universidade Federal do Rio Grande do Sul in Acta Scientiae Veterinariae
- Vol. 49
Extramedullary Plasmacytoma of the Third Eyelid in a Cat
Background: Extramedullary plasmacytoma is a neoplasm originating from plasmacytes with benign behavior, although it can present malignant characteristics such as local invasion and metastases in some cases. Primary extramedullary plasmacytoma in the third eyelid is rare in humans and animals and has not yet been described in cats. Thus, the goal of the present study is to describe the cytological and histopathological findings of an extramedullary plasmacytoma in a cat's third eyelid.Case: A 5-year-old female feline patient with a history of ocular alteration for approximately 30 days was referred to the ophthalmology service. Upon ophthalmic examination of the left eye, an increase in volume with tissue proliferation was identified in the third eyelid's conjunctiva. A collection of material for cytopathological examination was performed. Numerous plasmocytes and atypical lymphocytes with anisocytosis and anisokaryosis were observed, with a possible neoplastic injury being suggested and referred to the patient for surgical removal of the third eyelid. In the histopathological analysis, it was possible to observe several plasma cells and vascular neoformation along the entire conjunctive margin below the epithelium. The glands, serous and mucous, present in the fragment, revealed areas of intervening plasmacytic infiltrate and a large area close to the hyaline cartilage containing intense plasmacytic inflammatory infiltrate with rare neutrophils and macrophages. There was also a structural breakdown of glandular components and lymphocyte cells with mitosis figures and discrete cellular pleomorphism.Discussion: Plasmacytoma is a rare neoplasm in both dogs and cats. The anatomical regions most frequently affected are the digits, lips, and pinna. Concerning the 3rd eyelid tumor involvement, numerous types of neoplasms have been reported in dogs in the veterinary literature, including transmissible venereal tumor, squamous cell carcinoma, and melanocytoma melanoma, lymphoma, plasmacytoma, hemangioma, hemangiosarcoma, mastocytoma, and myoepithelioma. In cats, the third eyelid is the third site most affected by primary tumors. Adult and elderly animals are the most affected; however, an extramedullary plasmacytoma (PEM) has been reported in an eight-month-old male cat's skeletal muscle. Plasmacytoma aspirates, like other round cells, tend to be highly cellular, the cell morphology has a plasmacytoid aspect, resembling mature cells, the cytoplasm is intensely basophilic, and the round nucleus with an eccentric disposition has thin chromatin and indistinct nucleolus. Binucleate and multinucleate cells are common, and the absence of lymphoglandular corpuscles helps differentiate extramedullary plasmacytoma from lymphomas. Histologically, PEM is similar in dogs, humans, and felines, and variations in mature and immature plasma cells can be seen. The diagnosis of extramedullary plasmacytoma is fundamentally histological, and immunohistochemical analysis can also be performed. Surgical excision with safety margins is the primary type of treatment for neoplasms in the 3rd eyelid, being considered an effective method, as seen in this report, during the patient's follow-up for 13 months, no recurrence or metastasis of the neoplasm was seen. When signs of malignant neoplasms are found, it is recommended to evaluate the indication for chemotherapy before surgery and monitor the case after treatment due to recurrence risk.
- 1 January 2021
- Published by Universidade Federal do Rio Grande do Sul in Acta Scientiae Veterinariae
- Vol. 49
Open AccessExtramedullary Plasmacytoma of the Third Eyelid in a Cat
Background: Extramedullary plasmacytoma is a neoplasm originating from plasmacytes with benign behavior, although it can present malignant characteristics such as local invasion and metastases in some cases. Primary extramedullary plasmacytoma in the third eyelid is rare in humans and animals and has not yet been described in cats. Thus, the goal of the present study is to describe the cytological and histopathological findings of an extramedullary plasmacytoma in a cat's third eyelid.Case: A 5-year-old female feline patient with a history of ocular alteration for approximately 30 days was referred to the ophthalmology service. Upon ophthalmic examination of the left eye, an increase in volume with tissue proliferation was identified in the third eyelid's conjunctiva. A collection of material for cytopathological examination was performed. Numerous plasmocytes and atypical lymphocytes with anisocytosis and anisokaryosis were observed, with a possible neoplastic injury being suggested and referred to the patient for surgical removal of the third eyelid. In the histopathological analysis, it was possible to observe several plasma cells and vascular neoformation along the entire conjunctive margin below the epithelium. The glands, serous and mucous, present in the fragment, revealed areas of intervening plasmacytic infiltrate and a large area close to the hyaline cartilage containing intense plasmacytic inflammatory infiltrate with rare neutrophils and macrophages. There was also a structural breakdown of glandular components and lymphocyte cells with mitosis figures and discrete cellular pleomorphism.Discussion: Plasmacytoma is a rare neoplasm in both dogs and cats. The anatomical regions most frequently affected are the digits, lips, and pinna. Concerning the 3rd eyelid tumor involvement, numerous types of neoplasms have been reported in dogs in the veterinary literature, including transmissible venereal tumor, squamous cell carcinoma, and melanocytoma melanoma, lymphoma, plasmacytoma, hemangioma, hemangiosarcoma, mastocytoma, and myoepithelioma. In cats, the third eyelid is the third site most affected by primary tumors. Adult and elderly animals are the most affected; however, an extramedullary plasmacytoma (PEM) has been reported in an eight-month-old male cat's skeletal muscle. Plasmacytoma aspirates, like other round cells, tend to be highly cellular, the cell morphology has a plasmacytoid aspect, resembling mature cells, the cytoplasm is intensely basophilic, and the round nucleus with an eccentric disposition has thin chromatin and indistinct nucleolus. Binucleate and multinucleate cells are common, and the absence of lymphoglandular corpuscles helps differentiate extramedullary plasmacytoma from lymphomas. Histologically, PEM is similar in dogs, humans, and felines, and variations in mature and immature plasma cells can be seen. The diagnosis of extramedullary plasmacytoma is fundamentally histological, and immunohistochemical analysis can also be performed. Surgical excision with safety margins is the primary type of treatment for neoplasms in the 3rd eyelid, being considered an effective method, as seen in this report, during the patient's follow-up for 13 months, no recurrence or metastasis of the neoplasm was seen. When signs of malignant neoplasms are found, it is recommended to evaluate the indication for chemotherapy before surgery and monitor the case after treatment due to recurrence risk.
- Open Access
- 1 June 2020
- Published by FapUNIFESP (SciELO) in Pesquisa Veterinária Brasileira
- Vol. 40 (6) , 474-478
Evaluation of platelet-rich plasma gel as an angiogenesis-inducing agent in canineadvancement skin flaps
This work aimed to evaluate the effect of platelet-rich plasma (PRP) on advancement skin flaps in dogs regarding improvement of vascularization, with focus on increasing its viable area, since there are reports that it is a potential angiogenesis stimulator. The experimental group was composed of eight adult bitches, in which two advancement skin flaps were made in the ventral abdominal region. No product was applied in the control flap (CF), while PRP was used in the contralateral flap, called treated flap (TF). The areas were clinically evaluated every two days until the 7th postoperative day regarding skin color and presence of necrosis. At 10 days, both flaps were removed and submitted to histological examination and blood vessel morphometry. The vessels counted in each group were statistically analyzed by the F-test at 1% probability. Results showed no significant difference in macroscopic changes in the wound, or CF and TF vascularization, thus suggesting that PRP gel did not improve advancement skin flap angiogenesis in bitches under the experimental conditions in which this research was developed.
- 1 June 2020
- Published by FapUNIFESP (SciELO) in Pesquisa Veterinária Brasileira
- Vol. 40 (6) , 474-478
Open AccessEvaluation of platelet-rich plasma gel as an angiogenesis-inducing agent in canineadvancement skin flaps
This work aimed to evaluate the effect of platelet-rich plasma (PRP) on advancement skin flaps in dogs regarding improvement of vascularization, with focus on increasing its viable area, since there are reports that it is a potential angiogenesis stimulator. The experimental group was composed of eight adult bitches, in which two advancement skin flaps were made in the ventral abdominal region. No product was applied in the control flap (CF), while PRP was used in the contralateral flap, called treated flap (TF). The areas were clinically evaluated every two days until the 7th postoperative day regarding skin color and presence of necrosis. At 10 days, both flaps were removed and submitted to histological examination and blood vessel morphometry. The vessels counted in each group were statistically analyzed by the F-test at 1% probability. Results showed no significant difference in macroscopic changes in the wound, or CF and TF vascularization, thus suggesting that PRP gel did not improve advancement skin flap angiogenesis in bitches under the experimental conditions in which this research was developed.